Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

[1]  J. Mascola,et al.  Chimpanzee Adenovirus Vector Ebola Vaccine , 2017, The New England journal of medicine.

[2]  W. J. Ramsey,et al.  A Recombinant Vesicular Stomatitis Virus Ebola Vaccine , 2017, The New England journal of medicine.

[3]  E. Cave Voluntary vaccination: the pandemic effect , 2016, Legal Studies.

[4]  M. Altfeld,et al.  Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. , 2016, The New England journal of medicine.

[5]  John-Arne Røttingen,et al.  The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola , 2015, BMJ : British Medical Journal.

[6]  K. Chu,et al.  Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial , 2015, The Lancet.

[7]  W. Team Ebola virus disease among children in West Africa. , 2015 .

[8]  Edward Wright,et al.  A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. , 2015, The New England journal of medicine.

[9]  Christopher Dye,et al.  Ebola vaccine--an urgent international priority. , 2014, The New England journal of medicine.

[10]  Mikiko Senga,et al.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.

[11]  H. Feldmann,et al.  Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. , 2011, The Journal of infectious diseases.

[12]  Mario Roederer,et al.  CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates , 2011, Nature Medicine.

[13]  Claudio J. Struchiner,et al.  Design and Analysis of Vaccine Studies , 2009 .

[14]  P. Grambsch Survival and Event History Analysis: A Process Point of View by AALEN, O. O., BORGAN, O., and GJESSING, H. K. , 2009 .

[15]  Heinz Feldmann,et al.  Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus , 2009, Journal of Virology.

[16]  D. Torgerson,et al.  Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals , 2003, BMJ : British Medical Journal.

[17]  Allan Donner,et al.  Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .

[18]  K. Schulz,et al.  Subverting randomization in controlled trials. , 1995, JAMA.

[19]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.

[20]  D. Seto,et al.  Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report. , 2015, The New England journal of medicine.

[21]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[22]  Richard J. Hayes,et al.  Cluster randomised trials , 2009 .

[23]  F. Fenner Smallpox and its eradication , 1988 .